| Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis DF Alonso, HG Farina, G Skilton, MR Gabri, MS De Lorenzo, DE Gomez Breast cancer research and treatment 50, 83-93, 1998 | 175 | 1998 |
| Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial E Neninger, RM Díaz, A de La Torre, R Rives, A Díaz, G Saurez, ... Cancer Biology & Therapy 6 (2), 145-150, 2007 | 163 | 2007 |
| Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine A Carr, E Rodríguez, M del Carmen Arango, R Camacho, M Osorio, ... Journal of Clinical Oncology 21 (6), 1015-1021, 2003 | 128 | 2003 |
| Cancer vaccines: an update with special focus on ganglioside antigens RJ Bitton, MD Guthmann, MR Gabri, AJL Carnero, DF Alonso, L Fainboim, ... Oncology reports 9 (2), 267-276, 2002 | 126 | 2002 |
| Detection of N‐glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer AM Scursoni, L Galluzzo, S Camarero, J Lopez, F Lubieniecki, C Sampor, ... Journal of Immunology Research 2011 (1), 245181, 2011 | 120 | 2011 |
| NGcGM3 ganglioside: a privileged target for cancer vaccines LE Fernandez, MR Gabri, MD Guthmann, RE Gomez, S Gold, L Fainboim, ... Journal of Immunology Research 2010 (1), 814397, 2010 | 109 | 2010 |
| 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients. S Alfonso, RM Diaz, A De la Torre, E Santiesteban, F Aguirre, K Perez, ... Cancer biology & therapy 6 (12), 1847-1852, 2007 | 96 | 2007 |
| A web-and app-based connected care solution for COVID-19 in-and outpatient care: qualitative study and application development T Schinköthe, MR Gabri, M Mitterer, P Gouveia, V Heinemann, N Harbeck, ... JMIR public health and surveillance 6 (2), e19033, 2020 | 65 | 2020 |
| Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides. AM Vázquez, MR Gabri, AM Hernández, DF Alonso, I Beausoleil, ... Oncology Reports 7 (4), 751-757, 2000 | 64 | 2000 |
| Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity MD Guthmann, RJ Bitton, AJL Carnero, MR Gabri, G Cinat, L Koliren, ... Journal of Immunotherapy 27 (6), 442-451, 2004 | 61 | 2004 |
| Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry AM Scursoni, L Galluzzo, S Camarero, N Pozzo, MR Gabri, CM De Acosta, ... Pediatric and Developmental Pathology 13 (1), 18-23, 2010 | 54 | 2010 |
| Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data AM Vázquez, AM Hernández, A Macías, E Montero, DE Gómez, ... Frontiers in Oncology 2, 150, 2012 | 52 | 2012 |
| A Phase I Study of the Anti‐Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies W Cacciavillano, C Sampor, C Venier, MR Gabri, MTG de Dávila, ... Pediatric blood & cancer 62 (12), 2120-2124, 2015 | 46 | 2015 |
| Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy M Labrada, M Clavell, Y Bebelagua, J León, DF Alonso, MR Gabri, ... Expert opinion on biological therapy 10 (2), 153-162, 2010 | 46 | 2010 |
| Immunoreactivity of the 14F7 Mab raised against N‐Glycolyl GM3 Ganglioside in retinoblastoma tumours AV Torbidoni, A Scursoni, S Camarero, V Segatori, M Gabri, D Alonso, ... Acta ophthalmologica 93 (4), e294-e300, 2015 | 40 | 2015 |
| Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model D Fuentes, J Avellanet, A Garcia, N Iglesias, MR Gabri, DF Alonso, ... Breast cancer research and treatment 120, 379-389, 2010 | 40 | 2010 |
| Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines MR Gabri, LL Otero, DE Gomez, DF Alonso Journal of Experimental & Clinical Cancer Research 28, 1-8, 2009 | 38 | 2009 |
| A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma. DF Alonso, MR Gabri, MD Guthmann, L Fainboim, DE Gómez International journal of oncology 15 (1), 59-125, 1999 | 35 | 1999 |
| Association of cone-rod homeobox transcription factor messenger RNA with pediatric metastatic retinoblastoma AV Torbidoni, VE Laurent, C Sampor, D Ottaviani, V Vazquez, MR Gabri, ... JAMA ophthalmology 133 (7), 805-812, 2015 | 33 | 2015 |
| Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 … VE Laurent, C Sampor, V Solernou, J Rossi, M Gabri, S Eandi-Eberle, ... European Journal of Cancer 49 (13), 2892-2899, 2013 | 32 | 2013 |
